DK1408949T3 - Glycinbetain og dets brugområde for opfindelsen - Google Patents

Glycinbetain og dets brugområde for opfindelsen

Info

Publication number
DK1408949T3
DK1408949T3 DK02701110T DK02701110T DK1408949T3 DK 1408949 T3 DK1408949 T3 DK 1408949T3 DK 02701110 T DK02701110 T DK 02701110T DK 02701110 T DK02701110 T DK 02701110T DK 1408949 T3 DK1408949 T3 DK 1408949T3
Authority
DK
Denmark
Prior art keywords
scope
glycine betaine
betaine
glycine
Prior art date
Application number
DK02701110T
Other languages
English (en)
Inventor
Jallal Messadek
Original Assignee
Jallal Messadek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE2001/0085A external-priority patent/BE1013958A6/fr
Priority claimed from US09/945,391 external-priority patent/US6855734B2/en
Application filed by Jallal Messadek filed Critical Jallal Messadek
Application granted granted Critical
Publication of DK1408949T3 publication Critical patent/DK1408949T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02701110T 2001-02-05 2002-02-04 Glycinbetain og dets brugområde for opfindelsen DK1408949T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
BE2001/0085A BE1013958A6 (fr) 2001-02-05 2001-02-05 Antagonistes glycoproteiques.
US09/945,391 US6855734B2 (en) 1999-03-02 2001-08-31 Glycine betaine and its use
BEPCT/BE01/00222 2001-12-21
PCT/BE2002/000013 WO2002062322A2 (en) 2001-02-05 2002-02-04 Glycine betaine and its use as anti-hemorrhagic agent

Publications (1)

Publication Number Publication Date
DK1408949T3 true DK1408949T3 (da) 2008-04-28

Family

ID=27159516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02701110T DK1408949T3 (da) 2001-02-05 2002-02-04 Glycinbetain og dets brugområde for opfindelsen

Country Status (5)

Country Link
EP (1) EP1408949B1 (da)
CA (1) CA2441948A1 (da)
DK (1) DK1408949T3 (da)
ES (1) ES2298342T3 (da)
WO (1) WO2002062322A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
EP1615632B1 (fr) * 2003-04-17 2006-12-06 Jallal Messadek Formulations orales flottantes pour la liberation controlee de la betaine
CA2575760A1 (en) * 2003-08-04 2005-02-10 Jallal Messadek Selected betaines and their uses
BE1016128A6 (fr) * 2004-07-22 2006-03-07 Messadek Jallal Combinaisons therapeutiques
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
MX2007013486A (es) 2005-04-27 2008-03-14 Jallal Messadek Combinaciones de insulinas.
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
GB2447685A (en) * 2007-03-21 2008-09-24 Nozotec Ab Haemostatic and dentifrice compositions
CL2008001640A1 (es) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Uso de hidroxiprolina para preparar una composicion de alemento destinada a promover el crecimiento de un animal, como peces, aves y mamiferos.
WO2009065193A1 (en) * 2007-11-21 2009-05-28 Jallal Messadek Treatment of aspirin resistance with betaine and/or betaine enriched molasses
WO2021126159A1 (en) 2019-12-16 2021-06-24 Hill's Pet Nutrition, Inc. Pet food compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226386B (it) * 1988-07-08 1991-01-15 Chiesi Farma Spa Procedimento di preparazione di morniflumato e analoghi.
US5876780A (en) * 1993-04-29 1999-03-02 Cultor, Ltd. Compositions for treating coccidiosis
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
JP2000143486A (ja) * 1998-11-12 2000-05-23 Lion Corp 皮膚外用剤
BE1012495A3 (fr) * 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
BE1012546A6 (fr) * 1999-03-10 2000-12-05 Messadek Jallal La betaine et ses derives pour leur usage antithrombotique.
BE1012712A6 (fr) * 1999-06-10 2001-02-06 Messadek Jallal Peptides antithrombotiques.

Also Published As

Publication number Publication date
CA2441948A1 (en) 2002-08-15
EP1408949A2 (en) 2004-04-21
EP1408949B1 (en) 2007-12-19
WO2002062322A2 (en) 2002-08-15
WO2002062322A3 (en) 2002-11-28
ES2298342T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
DE60212600D1 (de) Audiocodierung und decodierung
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1637660T3 (da) Slidelement og slidaggregat
DK1746375T3 (da) Oxygendrevet forbrændingssystem og anvendelser deraf
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20040139L (no) N- (3-amino-2-hydroksy-propyl) substituerte alkylamidoforbindelser
DK1404809T3 (da) Forbedrede hudsubstitutter og anvendelser deraf
DE10196542T1 (de) Metalldichtung
DE60227134D1 (de) Verbindungsanordnung
DE60238910D1 (de) Metalldichtung
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1408949T3 (da) Glycinbetain og dets brugområde for opfindelsen
DE50200615D1 (de) Geminitenside
BR0207810A (pt) inibidores de deformilase de peptìdeo
DE50200250D1 (de) Geminitenside
DE50200466D1 (de) Symmetrierübertrager
DE60114244D1 (de) Osteosynthesevorrichtung
ITMI20010954A0 (it) Procedimento di iodurazione
DE50213801D1 (de) Gelenk
NO20032963L (no) Peptidforbindelser
GB0110996D0 (en) Improved bridge joint
DE60228171D1 (de) Metalldichtung
ATE373426T1 (de) Glutaminase
DE60219418D1 (de) Silanylphenole und -naphthole
ATE354561T1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen